FILSUVEZ® (birch triterpenes)
www.filsuvez.com
www.filsuvez.com
Filsvuez is approved for the treatment of wounds associated with dystrophic and junctional epidermolysis bullosa in adults and pediatric patients 6 months of age or older.
Filsvuez is approved for the treatment of wounds associated with dystrophic and junctional epidermolysis bullosa in adults and pediatric patients 6 months of age or older.